Regulatory Affairs

Posts in Category: Regulatory Affairs

Biosimilars Registration: SFDA Considerations
Published On: 16/03/2025By Regulatory Editor
Veterinary Drug Registration in SFDA
Published On: 08/02/2025By Abeer Mazyad
How to write Economic Evaluation Studies (EES) for SFDA?
Published On: 14/01/2025By Madiha Baaj
SaMD Registration in SFDA (Software as a Medical Device)
Published On: 07/12/2024By Yumna Siraj
MDMA Update and Change of Information
Published On: 06/12/2024By Mohamed Bashim
Overview of SFDA Conditional Approval for New Medicines
Published On: 02/12/2024By Madiha Baaj
SFDA Drug Pricing Rules in Saudi Arabia
Published On: 30/11/2024By Rawd Alsubaie
CAR T Cell Registration in SFDA
Published On: 08/07/2024By Regulatory Editor
Scientific Office Requirements by SFDA
Published On: 01/03/2024By Regulatory Editor
Reporting Medical Device Incidents & Adverse Events to SFDA
Published On: 23/02/2024By Heba Rasheed
Breakthrough Medicines Designation in SFDA
Published On: 12/02/2024By Madiha Baaj
How to implement PMCF in Saudi Arabia
Published On: 09/02/2024By Heba Rasheed

Regulatory Newsletter

Subscribe to receive the latest regulatory news and insights

Office Location

7164 Othman bn Affan Rd. Office No 13. Riyadh, 13317. Saudi Arabia.

Contact Us

Support@PharmaKnowl.com

+966-11-2777729

Business Hours

Sunday to Thursday:

9 am – 5 pm

© 2014 - 2025 • PharmaKnowl is a registered Trade Mark • All Content Rights are Reserved • Riyadh, Saudi Arabia

Contact Our Business Support Team

Sunday to Thursday: 9:00 am – 5:00 pm

+966 11 277 7729

+966 11 240 4409